Rchr
J-GLOBAL ID：201801009645370134   Update date: May. 01, 2025

Kazuhiro Morishita

モリシタ カズヒロ | Kazuhiro Morishita
Affiliation and department：
University of Miyazaki Faculty of Medicine

About University of Miyazaki Faculty of Medicine


Homepage URL  (1)： http://www.med.miyazaki-u.ac.jp/home/biochem1/
Research field  (7)： Tumor diagnostics and therapeutics ,  Virology ,  Medical biochemistry ,  Hematology and oncology ,  Genomics ,  Pathobiochemistry ,  Tumor biology
Research keywords  (7)： 抗体療法 ,  成人T細胞白血病 ,  HTLV-1 ,  レトロウイルス ,  ゲノム解析 ,  リンパ腫 ,  白血病
Papers (249)：
  • Yanuar Rahmat Fauzi, Shingo Nakahata, Kazuya Shimoda, Tadashi Matsuura, Shinji Hagiwara, Kentaro Inoue, Hiroshi Moritake, Kazuhiro Morishita. Anti-transferrin receptor antibody (JST-TFR09/PPMX-T003) induces ferroptosis in adult T-cell leukemia/lymphoma (ATLL) cells. Biochemical and Biophysical Research Communications. 2025. 756. 151564-151564
  • Tomonaga Ichikawa, Akira Suekane, Shingo Nakahata, Hidekatsu Iha, Kazuya Shimoda, Takashi Murakami, Kazuhiro Morishita. Inhibition of PRMT5/MEP50 Arginine Methyltransferase Activity Causes Cancer Vulnerability in NDRG2low Adult T-Cell Leukemia/Lymphoma. International journal of molecular sciences. 2024. 25. 5
  • Yu Wang, Shunsuke Shimosaki, Emi Ikebe, Hidekatsu Iha, Jun-ichi Yamamoto, Nichole Fife, Tomonaga Ichikawa, Mitsuo Hori, Masao Ogata, Yoshiyuki Tsukamoto, et al. IMiD/CELMoD-induced growth suppression of adult T-cell leukemia/lymphoma cells via cereblon through downregulation of target proteins and their downstream effectors. Frontiers in Oncology. 2024. 13
  • Kosuke Mochida, Shingo Nakahata, Yutaka Suzuki, Kentaro Inoue, Sayaka Moriguchi, Atsushi Yamashita, Masahiro Amano, Kazuhiro Morishita. Prognostic analysis of smoldering ATLL with skin eruptions based on genomic aberrations. Journal of Dermatological Science. 2023
  • Akira Suekane, Tomonaga Ichikawa, Yusuke Saito, Shingo Nakahata, Kazuhiro Morishita. The CGRP Receptor Antagonist MK0974 Induces EVI1high AML Cell Apoptosis by Disrupting ERK Signaling. Anticancer research. 2022. 42. 10. 4743-4752
ｍore...
MISC (54)：
ｍore...
Patents (33)：
ｍore...
Education (1)：
  • 1974 - 1980 University of Tsukuba
Professional career (1)：
  • 医学博士 (東京大学)
Work history (6)：
  • 2004/04 - 現在 University of Miyazaki Faculty of Medicine
  • 2000/04 - 2003/03 Miyazaki Medical College
  • 1992/10 - 2000/03 国立がん研究センター研究所 生物学部 主任研究員、室長
  • 1988/08 - 1992/09 St Jude Children's Research Hospital, Department of Biology Research fellow, Faculty member
  • 1987/01 - 1988/07 Frederick National Cancer Institute, T-cell leukemogenesis section,
Show all
Awards (1)：
  • 2006/07 - 日本白血病基金 クレディセゾン賞
Association Membership(s) (5)：
日本フォスファターゼ学会 ,  THE MOLECULAR BIOLOGY SOCIETY OF JAPAN ,  THE JAPANESE BIOCHEMICAL SOCIETY ,  THE JAPANESE SOCIETY OF HEMATOLOGY ,  THE JAPANESE CANCER ASSOCIATION
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM